Fintel reports that on February 28, 2025, Piper Sandler initiated coverage of Avalo Therapeutics (NasdaqCM:AVTX) with a Overweight recommendation. As of February 19, 2025, the average one-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback